



DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR 





Department of Quality Assurance, AISSMS College of Pharmacy, Kennedy Road, Near R. T. O., Pune 411001, Maharashtra, India 
Email: santoshvgandhi@rediffmail.com  
, PRASHANT S. MITTAL, ASHWINI M. GAIKWAD 
 Received: 18 Mar 2015 Revised and Accepted: 28 Apr 2015 
ABSTRACT 
Objective: To develop a validated stability indicating reverse phase high performance liquid chromatography (RP-HPLC) method for simultaneous 
estimation of Beclomethasone dipropionate (BEC) and Salbutamol sulphate (SAL) in bulk and combined dosage form. 
Methods: An isocratic, RP-HPLC method was developed using Hi Q Sil C18
Results: The chromatographic conditions yield good separation between drugs with retention time (RT) of 7.75±0.03 min and 2.36±0.09 min, for 
BEC and SAL, respectively. The method was validated with respect to linearity, precision, accuracy and robustness. The data of linear regression 
analysis indicated a good linear relationship over the range of 5–30 µg/ml concentrations with a correlation coefficient (r
 (250 x 4.6 mm, 5 µm) column and 1 mM ammonium acetate buffer and 
methanol (15:85 v/v) as mobile phase at flow rate of 1 ml/min and detection wavelength of 230 nm. 
2
Conclusion: The developed method was found to be simple, sensitive, selective, accurate, and repeatable for simultaneous analysis of BEC and SAL 
and can be adopted for routine analysis of these drugs in bulk and pharmaceutical dosage form. 
) of 0.997 for both the 
drugs. 
Keywords: High performance liquid chromatography (HPLC), Beclomethasone dipropionate, Salbutamol sulphate, Stability indicating, Validation. 
 
INTRODUCTION 
Beclomethasone dipropionate (BEC) chemicaly is 9 α-chloro-11β-
hydroxy-16 β-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl 
dipropionate (fig. 1-A) and Salbutamol sulphate (SAL) chemically is 
(RS)-1-(4-hydroxy-3-hydroxy-methylphenyl)-2-(tert-butylamino) 
ethanol sulphate (fig. 1-B). Beclomethasone dipropionate is a 
steroidal drug used in asthma; while Salbutamol Sulphate is a β2 
agonist. There may be many drugs in individual form, and in 
combination forms available in the market, but Salbutamol Sulphate 
in combination with Beclomethasone Dipropionate is a good 
combination in market used for the management of bronchial 
asthma [1]. 
Literature survey reveals several methods reported viz UV 
spectrophotometric [2, 3], simple HPLC [4-7] and Stability indicating 
HPLC method [8] for estimation of beclomethasone dipropionate 
alone and in combinations with other drugs; as well as simple UV 
spectrophotometric methods [9, 10], RP-HPLC method [11-13], 
stability indicating RP-HPLC [14, 15]and HPTLC [16] methods for 
estimation of Salbutamol sulphate alone and in combinations with 
other drugs are reported. Simple RP-HPLC method and Ultra 
Pressure liquid chromatography method for estimation of 
Beclomethasone dipropionate and Salbutamol sulphate combination 
[17, 18]are also reported.  
To the best of our knowledge no stability indicating RP-HPLC 
method has been reported for simultaneous estimation of 
Beclomethasone dipropionate and Salbutamol sulphate. The present 
work describes a simple stability indicating HPLC method for the 
simultaneous determination of Beclomethasone dipropionate and 
Salbutamol sulphate in bulk and pharmaceutical dosage form 
(Aerocort–Rota caps), according to the International conference on 





Fig. 1: Structure of A) Beclomethasone dipropionate and B) Salbutamol sulphate 
 
MATERIALS AND METHODS 
Reagents and chemicals 
Authentic sample of Beclomethasone dipropionate and Salbutamol 
sulphate were obtained from Cipla Pharmaceuticals Ltd, Mumbai, 
respectively. The formulation Aerocort–Rota caps (Manufactured 
by-Cipla Pharmaceuticals Ltd) labeled to contain Beclomethasone 
dipropionate (IP) 100 µg and Levosalbutamol sulphate (IP) 
equivalent to salbutamol 100 µg was procured form local market. 
Methanol (HPLC grade) was obtained from S. D. Fine Chem. Limited 
(Mumbai, India), HPLC grade water is collected at college using 
ELGA water purification system, ammonium acetate, glacial acetic 
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acid, hydrochloric acid (HCl), sodium hydroxide (NaOH), hydrogen 
peroxide (H2O2) (all are AR grade) were purchased from S. D. Fine 
Chem. Limited (Mumbai, India). 
Chromatographic condition 
HPLC system used was JASCO system equipped with Model PU 2080 
Plus pump, Rheodyne sample injection port (20 μl), MD 2010 PDA 
detector and Borwin-PDA software (version 1.5). A chromatographic 
column Hi Q Sil C18
 
Fig. 2: Overlay UV-VIS Spectra of BEC (10 µg/ml) and SAL (10 
µg/ml) 
 
Preparation of sample solution (Rota caps formulation 
analysis) 
 (250 x 4.6 mm, 5 µm) was used. Separation was 
carried out at a flow rate of 1 ml/min using 1 mM ammonium 
acetate buffer: methanol (15:85 v/v) as mobile phase and detection 
at 230 nm.  
Preparation of 1 mM ammonium acetate buffer and mobile 
phase  
1 mM ammonium acetate buffer was prepared by dissolving 7.71 mg 
of ammonium acetate in 80 ml of HPLC grade water, add 5.7 µl 
glacial acetic acid and make the volume up to 100 ml with HPLC 
grade water [22]. Mobile phase was prepared by mixing 1 mM 
Ammonium acetate buffer and methanol in the ratio of 15: 85 v/v. It 
was then filtered through 0.45 μm membrane filter paper using 
filtration assembly and then sonicated on ultrasonic water bath for 
15 min. 
Preparation of standard stock solution 
Standard stock solution of each drug was prepared separately by 
dissolving 10 mg of the drug in 10 ml of methanol to get concentration of 
1000 µg/ml (A). From the respective standard stock solution, working 
standard solution was prepared containing 100 µg/ml of 
Beclomethasone dipropionate and Salbutamol sulphate in mobile phase 
separately (B). From this further dilution was made in the mobile phase 
to get a final concentration of 10 µg/ml for Beclomethasone 
dipropionate and Salbutamol sulphate, separately. 
Selection of detection wavelength 
From the standard stock solution (1000 µg/ml) further dilutions 
were made using methanol and scanned over the range of 200-400 
nm and the spectra was obtained. It was observed that both the drug 
showed considerable absorbance at 230 nm. (fig. 2)  
 
Twenty capsules each containing 100 µg of Beclomethasone 
dipropionate and Levosalbutamol sulphate (equivalent to 
salbutamol 100 µg) were emptied and weighed. Powder equivalent 
to 10 mg of Beclomethasone dipropionate and 12.049 mg of 
salbutamol sulphate (equivalent to 10 mg of Salbutamol) was 
transferred to 10 ml volumetric flask and was diluted with 
methanol, sonicated for 10 min and volume made to 10 ml with 
methanol. Solution was filtered and further dilutions were made 
with mobile phase to get the final concentration of 10 µg/ml of 
Beclomethasone dipropionate and 12.049 µg/ml of salbutamol 
sulphate. 
Stress degradation studies of bulk drug 
Stability studies were carried out to provide evidence on how the quality 
of drug varies under the influence of a variety of environmental 
conditions like hydrolysis, oxidation, temperature, etc. and to establish 
specific storage conditions, shelf-life and retest period. Dry heat and 
photolytic degradation were carried out in the solid state. 
Alkaline hydrolysis 
1 ml working standard solution of BEC (100 µg/ml) was mixed with 
1 ml of 0.01 N NaOH (Methanolic) and kept aside for 6 hours at room 
temperature, after exposure the volume was made up to 10 ml with 
the mobile phase and injected; SAL was treated in a similar manner 
to BEC.  
Acid hydrolysis 
1 ml working standard solution of BEC (100 µg/ml) was mixed with 
1 ml of 0.1 N HCl (Methanolic) and kept aside for 24 hours at room 
temperature, after exposure the volume was made up to 10 ml with 
the mobile phase and injected; SAL was treated in a similar manner 
to BEC.  
Neutral hydrolysis  
1 ml working standard solution of BEC (100 µg/ml) was mixed with 
1 ml water, and was kept aside for 24 hours at room temperature, 
after exposure the volume was made up to 10 ml with the mobile 
phase and injected; SAL is treated in a similar manner to BEC.  
Degradation under oxidative condition  
1 ml working standard solution of BEC (100 µg/ml) was mixed with 1 ml 
of 30 % solution of H2O2
 
 and was kept aside for 2 hours at room 
temperature, after exposure the volume was made up to 10 ml with the 
mobile phase and injected; SAL was treated in a similar manner to BEC.  
Degradation under dry heat 
Dry heat studies were performed by keeping drug sample separately 
in oven (60 °C) for a period of 24 hours. A sample were withdrawn 
after 24 hours, dissolved in methanol to get solution of 1000 µg/ml 
and further diluted with mobile phase to get 10 µg/ml as final 
concentration and was injected.  
Photo-degradation studies 
Photolytic studies were carried out by exposure of drug to UV light up 
to 200 watt hours/square meter and subsequently to cool fluorescent 
light to achieve an illumination of 1.2 million Lux Hrs. The sample was 
weighed, dissolved and diluted to get 10 µg/ml and injected. 
RESULTS AND DISCUSSION 
Optimization of chromatographic conditions 
The primary target in developing this stability indicating HPLC method 
is to achieve the resolution between BEC, SAL and its degradation 
products.  
 
Fig. 3: Chromatogram of mixture containing BEC (10 µg/ml) and 
SAL (10 µg/ml).
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To achieve the separation, we used a stationary phase C18 column and 
mobile phase 1 mM ammonium acetate buffer and methanol in the 
ratio 15:85, v/v. The tailing factor obtained was less than two and 
retention time was 7.75±0.03 min and 2.36±0.05 min for BEC and SAL, 
respectively (Fig.3). Forced degradation study showed the method is 
highly specific and no degradation products were eluted at retention 
time of drugs. (fig. 4 and fig. 5). Summary of stress degradation studies 














Fig. 4: Representative chromatogram of Alkali (A), Acid (B), Neutral (C), Oxidative (D), Dry Heat (E), Photolytic (F) degradation of 
Beclomethasone dipropionate 
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Fig. 5: Representative chromatogram of Alkali (A), Acid (B), Neutral (C), Oxidative (D), Dry Heat (E) Photolytic (F) degradation of 
Salbutamol sulphate 
 
Table 1: Summary of stress degradation study of BEC and SAL (n=3) 
S. No. Stress degradation condition % Recovery (BEC) % Recovery (SAL) 
1 Base (0.01 N NaOH Methanolic), Kept for 6 hours. 76.45 89.57 
2 Acid (0.1 N HCl Methanolic), Kept for 24 hours. 65.81 80.42 
3 Neutral (kept for 24 hours.) 73.37 71.31 
4 H2O2 60.99 , 30% (kept for 2 hours.) 94.68 
5 Dry heat (60 °C for 24 hours.) 75.83 82.10 
6 
 
Photo stability (UV, 200 watt, hrs/square meter and Florescence,  
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Validation of analytical method 
Specificity 
The specificity of the method was ascertained by peak purity profile 
studies. The peak purity values were found to be more than 991, 
indicating the no interference of any other peak of degradation 
product, impurity or matrix. 
Linearity 
The linearity (relationship between peak area and concentration) 
was determined by analyzing six solutions over the concentration 
range of 5-30 µg/ml for BEC and SAL, five replicates per 
concentrations were analyzed, the equation of calibration curve was 
found to be y = 20407 x+58659 for BEC with r2 = 0.997 and y = 
22675.4 x+8355 for SAL with r2
For the inter day variation studies, 3 different concentrations were 
analyzed on 3 consecutive days and percentage RSD was calculated. 
The results obtained for Intraday and Inter day variations were 
found to be within limits (less than 2% RSD). 
 = 0.997. 
Precision 
The precision of the method was demonstrated by Intra-day and Inter-
day variation studies. In the Intra-day studies, 6 replicates of BEC (10 
µg/ml) and 6 replicates of SAL (10µg/ml) were analyzed in a day and 
percentage relative standard deviation %RSD was calculated.  
Limit of detection (LOD) and limit of quantitation (LOQ) 
From the linearity data the LOD and LOQ was calculated, using the 
formula LOD = 3.3 σ/S and LOQ = 10 σ/S Where, σ = standard 
deviation of the y intercept of linearity equations and S = slope of the 
calibration curve of the analyte. LOD of BEC and SAL was found to be 
0.637 µg/ml and 0.221 µg/ml, respectively. LOQ of BEC and SAL was 
found to be 1.932 µg/ml and 0.67 µg/ml, respectively. 
Assay 
Rota caps formulation analysis was carried out as mentioned under 
section preparation of sample solution; Procedure was repeated for 
six times. Sample solution was injected and area was recorded for 
each drug. Concentration and % purity was determined from linear 
equation. (table no: 2) 
Accuracy  
To check accuracy of the method, recovery studies were carried by 
spiking the standard drug to the rotacaps sample solution, at three 
different levels around 50, 100 and 150 %. Basic concentration of 
sample solution chosen was 10 µg/ml of BEC and 12.049 µg/ml of 
SAL. % recovery was determined from linearity equation. The 
results obtained are shown in (table no: 3). 
 
Table 2: Assay of marketed formulation-rotacaps 















 1 265159.7 10.119 101.191 281938.1 12.06 100.13 
 2 261497.9 9.939 99.396 279786.04 11.96 99.34 
 3 270145.6 10.363 103.63 277145.9 11.85 98.37 
 4 259927.9 9.862 98.627 280200.07 11.98 99.49 
 5 262412.5 9.984 99.84 279989.13 11.97 99.41 
 6 267852.7 10.251 104.277 281567.86 12.048 99.99 
 Mean 264499.4 10.087 100.87 280104.4 11.984 99.46 
 SD 3945.2 0.193 1.933 1695.83 0.074 0.62 
 %RSD 1.492 1.917 1.917 0.605 0.624 0.624 
 
Table 3: Recovery studies of BEC and SAL 
Level 
(%) 
Sample Standard. % Recovery±RSD 
BEC (µg/ml) SAL (µg/ml) BEC (µg/ml) SAL (µg/ml) BEC SAL 
 50 10 12.04 5 5 100.69*±1.9 99.68*±1.56 
 100 10 12.04 10 10 101.18*±1.5 99.0 *±1.24 
 150 10 12.04 15 15 101.08*±1.7 99.61*±1.05 
*Mean of three determinations 
 
Robustness 
Robustness of the method was determined by carrying out the 
analysis under conditions during which mobile phase composition, 
detection wavelength, flow rate were altered and the effect on the 
peak area was noted. The method was found to be robust as % RSD 
value found were less than 2%. 
CONCLUSION 
The developed method was found to be simple, sensitive, selective, 
accurate, and repeatable for simultaneous analysis of 
Beclomethasone dipropionate and Salbutamol sulphate in bulk and 
pharmaceutical dosage form without any interference from the 
excipients,  
The results indicated the suitability of the method to study stability 
of Beclomethasone dipropionate and Salbutamol sulphate under 
various forced degradation conditions like hydrolysis, oxidation, dry 
heat and photolytic degradation. 
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